Clinical trials: Arsenic Trioxide
Chronic Graft-Versus-Host Disease, Immune System Diseases
Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
This study aims to evaluate the early chronic GvHD events (first line therapy), if the addition of arsenic trioxide to standard therapy with corticosteroids, with or without cyclosporine, will be effective in controlling chronic…
- Trial name
- GvHD-ATO (NCT02966301)
- Testing
- Arsenic Trioxide Injectable Solution
- Volunteers
- 21 people
- Sponsor
- Medsenic
Acute Myeloid Leukemia
Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
The primary objective of this study is to determine whether low-dose cytarabine in combination with arsenic trioxide is more effective than low-dose cytarabine alone in achieving complete remission in elderly patients (≥60 years…
- Trial name
- NCT00513305
- Testing
- Arsenic trioxide, Low-dose cytarabine alone
- Where
- 12 sites in United States, Canada
- Volunteers
- 67 people
- Sponsor
- Cephalon